All charts and data below are CPI-U inflation-adjusted and with dividends reinvested. (Why?)
IHE real return snapshot: after CPI-U inflation, IHE returned +34.90% over the past year and +26.64% YTD, with dividends reinvested. Since May 5, 2006, IHE is up +434.55% in real purchasing-power return, or +8.51%/yr, and is currently −0.06% below its real total-return high on Nov. 11, 2026.
Data ending Fri Nov. 13, 2026
| Fri 2006-05-05💬 to Fri 2026-11-13 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| IHE × |
+434.55%
+8.51%/yr |
+8.01%/yr
R2=0.832 |
||||
| iShares U.S. Pharmaceuticals ETF Exchange-Traded Fund | ||||||
| Fri 2006-05-05💬 to Fri 2026-11-13 |
Start
Value |
End
Value |
|---|---|---|
| IHE × |
$10,000.00
2006-05-05 |
$53,454.69
2026-11-13 |
| YTD | YoY | |
|---|---|---|
| IHE × | +26.64% | +34.90% |
|
Current
Drawdown |
Worst
Drawdown |
|
|---|---|---|
| IHE × |
−0.06%
on 2026-11-13 from 2026-11-11 peak |
−39.57%
on 2009-03-05 from 2007-05-22 peak |
| Period ending Fri 2026-11-13 | 1 yr | 2 yr | 3 yr | 5 yr | 10 yr |
|---|---|---|---|---|---|
| IHE × | +34.90% |
+54.53% +24.31%/yr |
+85.90% +22.96%/yr |
+52.09% +8.75%/yr |
+87.32% +6.48%/yr |
| Year | IHE |
|---|---|
| 2026 (YTD) | +26.64% |
| 2025 | +28.26% |
| 2024 | +5.10% |
| 2023 | −2.21% |
| 2022 | −10.65% |
| 2021 | +5.63% |
| 2020 | +12.13% |
| 2019 | +12.89% |
| 2018 | −9.49% |
| 2017 | +8.35% |
| 2016 | −13.54% |
| 2015 | +8.02% |
| 2014 | +28.93% |
| 2013 | +38.51% |
| 2012 | +11.45% |
| 2011 | +17.46% |
| 2010 | +11.05% |
| 2009 | +26.66% |
| 2008 | −15.00% |
| 2007 | −1.66% |
| 2006 | +6.44% |
